Developer docs
API playgroundTry for free, no card

Search company profiles

3Analytics

Full company profile

uuid0002voi

Namestring
3Analytics
Legal namestring
3Analytics India Private Limited
Websiteurl
3analytics.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

3Analytics is a privately held AI-driven pharmacovigilance and safety analytics company founded in January 2020 in Silicon Valley, California, with operational headquarters in Frisco, Texas and a wholly-owned India subsidiary (3Analytics India Private Limited) in Chennai. The company operates a GxP-compliant, cloud-based SaaS platform built on a proprietary ADR/AE Analytics Engine that combines natural language processing across 100+ languages, machine learning, and statistical signal detection (including PRR, ROR, IC, regression models, and Tree Scan Statistics) to address safety monitoring for drugs, medical devices, vaccines, biologics, and cosmetics.

Its commercial product suite comprises four core modules: Signals (AI-powered signal management), Bio-Med Literature (automated ICSR extraction from medical literature), RegIntel (regulatory intelligence across 100+ countries with the Luna AI assistant), and an IMDRF Automated Coding Solution (95% claimed accuracy, 72% cost reduction). The company cites regulatory validation through a WHO shortlisting for active vaccine safety surveillance and a strategic partnership with JHPIEGO (Johns Hopkins Public Health Affiliate), alongside an enterprise GTM partnership with AssurX announced in 2025.

3Analytics monetizes primarily through annual SaaS subscriptions on a quote-based enterprise pricing model, supplemented by professional services for implementation and customization. It sells through direct enterprise field sales led by a VP of Sales with 25+ years of healthcare software experience, supported by educational webinars, content marketing, and channel partnerships. The disclosed customer base is concentrated in pharmaceutical companies, medical device manufacturers, vaccine producers, and public health organizations, with named enterprise references in pharma and medical devices.

Short descriptiontext

3Analytics is an AI-driven pharmacovigilance SaaS platform serving pharmaceutical, medical device, vaccine, and cosmetics companies. Its proprietary ADR/AE Analytics Engine powers signal management, literature monitoring, regulatory intelligence, and IMDRF coding solutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCupertino, United States
HQ citystring
Cupertino
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance analytics, drug safety monitoring, adverse event detection, regulatory compliance software, medical device surveillance
Industry3 codes
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGALAC
Signal Detection & Safety Analytics (Epidemiology/RWE)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Pharmacovigilance Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Cloud-based software-as-a-service platform providing pharmacovigilance and regulatory compliance solutions. Subscription-based model with tiered offerings for signal management, literature monitoring, regulatory intelligence, and IMDRF coding

3analytics.com
2Professional Services
TypeProfessional Services
Description

Implementation, customization, and consulting services for tailoring AI-driven solutions to unique customer needs

3analytics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise solutions with customized pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; no public pricing available. Book a demo to discuss requirements.

3analytics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Signals
Description

AI-driven Signal Management platform for drug, device, and vaccine safety signal detection and compliance.

3analytics.com
+4 more records
Core offering1 text field

3Analytics sells a cloud-based, AI/ML/NLP-driven pharmacovigilance SaaS platform that helps pharmaceutical, medical device, vaccine, and cosmetics organizations detect safety signals, automate literature monitoring and ICSR extraction, manage regulatory intelligence across 100+ countries, and code medical device complaints using IMDRF standards. The platform is built on a proprietary ADR/AE Analytics Engine and is delivered primarily via enterprise subscriptions with associated professional services for implementation and customization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% AI coding accuracy for IMDRF medical device complaint processing
+3 more records
Product overview1 text field

3Analytics offers a platform-plus-modules architecture built on its proprietary ADR/AE Analytics Engine. The product suite comprises four core modules: Signals (AI-powered signal management platform), Bio-Med Literature (automated literature monitoring and ICSR extraction), RegIntel (global regulatory intelligence), and IMDRF (automated medical device complaint coding). These integrated solutions share the common analytics engine and collectively address drug safety, medical device vigilance, vaccine pharmacovigilance, and cosmetovigilance, enabling end-to-end compliance management from signal detection through regulatory reporting.

Product and service4 records
1Signals (Signal Management Platform)
CategoryPharmacovigilance Signal Management
Description

AI-powered platform for detecting, validating, and managing safety signals for drugs, devices, and vaccines, combining qualitative and quantitative analytics with 20+ advanced algorithms (PRR, ROR, IC, regression models, Tree Scan Statistics), real-time detection, workflow automation, and audit-ready compliance reporting.

2Bio-Med Literature Platform
CategoryLiterature Monitoring and ICSR Extraction
Description

Automated literature monitoring platform that identifies Individual Case Safety Reports (ICSRs) from medical and scientific literature, with AI-powered ICSR extraction, duplicate detection, multi-language support in 100+ languages, and E2B R3 compliant export for safety databases and regulatory submissions.

3RegIntel (Regulatory Intelligence Platform)
CategoryRegulatory Intelligence
Description

Global regulatory intelligence platform providing real-time updates on regulatory requirements across 100+ countries, featuring the Luna AI assistant for instant regulatory queries, tailored reporting for Biologics, Drugs, Medical Devices, and Vaccines, and visualization dashboards covering Clinical Trial, Pre-Marketing, and Post-Marketing stages.

4IMDRF (Automated Coding Solution)
CategoryMedical Device Coding and Post-Market Surveillance
Description

AI-driven IMDRF coding solution for medical device complaint management that automates real-time complaint coding, handles multiple allegations per complaint, and ensures compliance with EU MDR and FDA guidelines, integrating with QMS and achieving up to 72% cost reduction with documented 95% accuracy.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2025-09-16
Description

Partnership webinar on Predictive Intelligence for Medical Device Safety in Post-Market Surveillance. Joint event to demonstrate integrated solutions for proactive safety management, combining data from MAUDE, complaints, QMS, and real-world evidence

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Strategic partnership with JHPIEGO, a Johns Hopkins Public Health Affiliate, positioning 3Analytics as a trailblazer in integrating pharmacovigilance with public health initiatives

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Shortlisted by WHO for active vaccine safety surveillance, demonstrating recognition of the company's capabilities in vaccine pharmacovigilance and public health technology

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Oracle's Argus Safety is the dominant pharmacovigilance safety database platform used by the majority of large pharmaceutical companies. It directly competes with 3Analytics' Signals platform in ICSR management, signal detection, and regulatory reporting workflows.

TypeDirect peer
Description

Veeva Vault Safety is a cloud-native pharmacovigilance suite used across life sciences for case management and signal detection. It competes with 3Analytics across the same PV workflow and increasingly serves medical device and vaccine manufacturers.

TypeDirect peer
Description

ArisGlobal's LifeSphere Safety platform offers pharmacovigilance, signal management, and regulatory intelligence for life sciences companies. It is a direct competitor to 3Analytics' Signals and RegIntel offerings across drug, device, and vaccine safety.

TypeBroad incumbent
Description

IQVIA offers pharmacovigilance and safety analytics as part of a broader technology and services portfolio spanning clinical, real-world evidence, and commercial. It overlaps with 3Analytics in signal detection and safety analytics but also bundles CRO-scale services.

TypeDirect peer
Description

Insife provides pharmacovigilance and signal management software (HALOPV) focused on AI-driven safety analytics for pharma and device manufacturers. It is a direct niche competitor to 3Analytics' Signals platform with similar AI and signal detection capabilities.

TypeDirect peer
Description

AB Cube (now part of Veeva) offers safety database solutions including E2B gateway and pharmacovigilance platforms. It is a direct competitor in the case management and safety reporting space relevant to 3Analytics' Bio-Med Literature and Signals modules.

TypeDirect peer
Description

Instem's BioClin division provides pharmacovigilance, signal detection, and literature monitoring software for life sciences. It is a direct competitor to 3Analytics' Bio-Med Literature and signal management offerings.

TypeOthers
Description

Cognizant delivers pharmacovigilance services and AI-enabled safety platforms for pharma and device companies. It competes for the same enterprise PV budgets and increasingly bundles signal detection and literature monitoring capabilities similar to 3Analytics.

TypeEmerging player
Description

Saama applies AI and data analytics across clinical development, regulatory, and safety workflows for life sciences. It overlaps with 3Analytics in AI-driven safety and regulatory intelligence and represents an emerging AI-native competitor.

TypeEmerging player
Description

AssurX provides quality management and complaint handling software for medical device manufacturers. 3Analytics co-presented a webinar with AssurX in 2025 on predictive intelligence for medical device safety, indicating adjacent offering overlap in IMDRF coding and post-market surveillance.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

3Analytics

Pharmacovigilance Software3analytics.com

3Analytics is an AI-driven pharmacovigilance SaaS platform serving pharmaceutical, medical device, vaccine, and cosmetics companies. Its proprietary ADR/AE Analytics Engine powers signal management, literature monitoring, regulatory intelligence, and IMDRF coding solutions globally.

What 3Analytics does

3Analytics is a privately held AI-driven pharmacovigilance and safety analytics company founded in January 2020 in Silicon Valley, California, with operational headquarters in Frisco, Texas and a wholly-owned India subsidiary (3Analytics India Private Limited) in Chennai. The company operates a GxP-compliant, cloud-based SaaS platform built on a proprietary ADR/AE Analytics Engine that combines natural language processing across 100+ languages, machine learning, and statistical signal detection (including PRR, ROR, IC, regression models, and Tree Scan Statistics) to address safety monitoring for drugs, medical devices, vaccines, biologics, and cosmetics.

Its commercial product suite comprises four core modules: Signals (AI-powered signal management), Bio-Med Literature (automated ICSR extraction from medical literature), RegIntel (regulatory intelligence across 100+ countries with the Luna AI assistant), and an IMDRF Automated Coding Solution (95% claimed accuracy, 72% cost reduction). The company cites regulatory validation through a WHO shortlisting for active vaccine safety surveillance and a strategic partnership with JHPIEGO (Johns Hopkins Public Health Affiliate), alongside an enterprise GTM partnership with AssurX announced in 2025.

3Analytics monetizes primarily through annual SaaS subscriptions on a quote-based enterprise pricing model, supplemented by professional services for implementation and customization. It sells through direct enterprise field sales led by a VP of Sales with 25+ years of healthcare software experience, supported by educational webinars, content marketing, and channel partnerships. The disclosed customer base is concentrated in pharmaceutical companies, medical device manufacturers, vaccine producers, and public health organizations, with named enterprise references in pharma and medical devices.

3Analytics firmographics

Firmographics
Name
3Analytics
Legal name
3Analytics India Private Limited
Website
https://3analytics.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
3Analytics is an AI-driven pharmacovigilance SaaS platform serving pharmaceutical, medical device, vaccine, and cosmetics companies. Its proprietary ADR/AE Analytics Engine powers signal management, literature monitoring, regulatory intelligence, and IMDRF coding solutions globally.
Ownership category
akta.pro rank

3Analytics industry classification

Industry
Product category
Pharmacovigilance Software
NAICS
Software Publishers (5132), Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGALAC
Signal Detection & Safety Analytics (Epidemiology/RWE)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pharmacovigilance analytics
  • Drug safety monitoring
  • Adverse event detection
  • Regulatory compliance software
  • Medical device surveillance

Where 3Analytics is headquartered

Location

Headquarters

HQ city
Cupertino
HQ country
United States
HQ region
North America

Offices3 records

Markets served

3Analytics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Platform Subscription: Cloud-based software-as-a-service platform providing pharmacovigilance and regulatory compliance solutions. Subscription-based model with tiered offerings for signal management, literature monitoring, regulatory intelligence, and IMDRF coding
  2. Professional Services: Implementation, customization, and consulting services for tailoring AI-driven solutions to unique customer needs

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise solutions with customized pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

3Analytics product offering

Product offering

Core offering

3Analytics sells a cloud-based, AI/ML/NLP-driven pharmacovigilance SaaS platform that helps pharmaceutical, medical device, vaccine, and cosmetics organizations detect safety signals, automate literature monitoring and ICSR extraction, manage regulatory intelligence across 100+ countries, and code medical device complaints using IMDRF standards. The platform is built on a proprietary ADR/AE Analytics Engine and is delivered primarily via enterprise subscriptions with associated professional services for implementation and customization.

Product overview

3Analytics offers a platform-plus-modules architecture built on its proprietary ADR/AE Analytics Engine. The product suite comprises four core modules: Signals (AI-powered signal management platform), Bio-Med Literature (automated literature monitoring and ICSR extraction), RegIntel (global regulatory intelligence), and IMDRF (automated medical device complaint coding). These integrated solutions share the common analytics engine and collectively address drug safety, medical device vigilance, vaccine pharmacovigilance, and cosmetovigilance, enabling end-to-end compliance management from signal detection through regulatory reporting.

Differentiator

Problem solved

Functional benefit

Brands

  • Signals: AI-driven Signal Management platform for drug, device, and vaccine safety signal detection and compliance.
  • Bio-Med Literature
  • IMDRF Coding Solution
  • RegIntel
  • Luna

Products and services

  • Signals (Signal Management Platform) AI-powered platform for detecting, validating, and managing safety signals for drugs, devices, and vaccines, combining qualitative and quantitative analytics with 20+ advanced algorithms (PRR, ROR, IC, regression models, Tree Scan Statistics), real-time detection, workflow automation, and audit-ready compliance reporting.
  • Bio-Med Literature Platform Automated literature monitoring platform that identifies Individual Case Safety Reports (ICSRs) from medical and scientific literature, with AI-powered ICSR extraction, duplicate detection, multi-language support in 100+ languages, and E2B R3 compliant export for safety databases and regulatory submissions.
  • RegIntel (Regulatory Intelligence Platform) Global regulatory intelligence platform providing real-time updates on regulatory requirements across 100+ countries, featuring the Luna AI assistant for instant regulatory queries, tailored reporting for Biologics, Drugs, Medical Devices, and Vaccines, and visualization dashboards covering Clinical Trial, Pre-Marketing, and Post-Marketing stages.
  • IMDRF (Automated Coding Solution) AI-driven IMDRF coding solution for medical device complaint management that automates real-time complaint coding, handles multiple allegations per complaint, and ensures compliance with EU MDR and FDA guidelines, integrating with QMS and achieving up to 72% cost reduction with documented 95% accuracy.

Quantifiable outcome

  • 95% AI coding accuracy for IMDRF medical device complaint processing
  • +3 more outcomes

Companies that use 3Analytics

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

3Analytics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

3Analytics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • AssurXflagshipGTM or Marketing Partner · 16 September 2025Partnership webinar on Predictive Intelligence for Medical Device Safety in Post-Market Surveillance. Joint event to demonstrate integrated solutions for proactive safety management, combining data from MAUDE, complaints, QMS, and real-world evidence
  • JHPIEGO (Johns Hopkins Public Health Affiliate)coreStrategic or Co-development Partner · 1 January 2020Strategic partnership with JHPIEGO, a Johns Hopkins Public Health Affiliate, positioning 3Analytics as a trailblazer in integrating pharmacovigilance with public health initiatives
  • World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 2020Shortlisted by WHO for active vaccine safety surveillance, demonstrating recognition of the company's capabilities in vaccine pharmacovigilance and public health technology

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

3Analytics competitors and assessment

Company assessment

Direct peers

  • Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is the dominant pharmacovigilance safety database platform used by the majority of large pharmaceutical companies. It directly competes with 3Analytics' Signals platform in ICSR management, signal detection, and regulatory reporting workflows.
  • Veeva Systems (Vault Safety): Veeva Vault Safety is a cloud-native pharmacovigilance suite used across life sciences for case management and signal detection. It competes with 3Analytics across the same PV workflow and increasingly serves medical device and vaccine manufacturers.
  • ArisGlobal (LifeSphere): ArisGlobal's LifeSphere Safety platform offers pharmacovigilance, signal management, and regulatory intelligence for life sciences companies. It is a direct competitor to 3Analytics' Signals and RegIntel offerings across drug, device, and vaccine safety.
  • Insife: Insife provides pharmacovigilance and signal management software (HALOPV) focused on AI-driven safety analytics for pharma and device manufacturers. It is a direct niche competitor to 3Analytics' Signals platform with similar AI and signal detection capabilities.
  • AB Cube: AB Cube (now part of Veeva) offers safety database solutions including E2B gateway and pharmacovigilance platforms. It is a direct competitor in the case management and safety reporting space relevant to 3Analytics' Bio-Med Literature and Signals modules.
  • Instem (BioClin): Instem's BioClin division provides pharmacovigilance, signal detection, and literature monitoring software for life sciences. It is a direct competitor to 3Analytics' Bio-Med Literature and signal management offerings.

Broad incumbents

  • IQVIA (Safety & Regulatory): IQVIA offers pharmacovigilance and safety analytics as part of a broader technology and services portfolio spanning clinical, real-world evidence, and commercial. It overlaps with 3Analytics in signal detection and safety analytics but also bundles CRO-scale services.

Others

  • Cognizant Life Sciences: Cognizant delivers pharmacovigilance services and AI-enabled safety platforms for pharma and device companies. It competes for the same enterprise PV budgets and increasingly bundles signal detection and literature monitoring capabilities similar to 3Analytics.

Emerging players

  • Saama Technologies: Saama applies AI and data analytics across clinical development, regulatory, and safety workflows for life sciences. It overlaps with 3Analytics in AI-driven safety and regulatory intelligence and represents an emerging AI-native competitor.
  • AssurX: AssurX provides quality management and complaint handling software for medical device manufacturers. 3Analytics co-presented a webinar with AssurX in 2025 on predictive intelligence for medical device safety, indicating adjacent offering overlap in IMDRF coding and post-market surveillance.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

3Analytics social profiles

Digital presence

3Analytics compliance and trust

Trust signal

Compliance3 records

3Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

3Analytics leadership team

Management profile

Number of profiles

Profiles14 records

3Analytics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

3Analytics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

3Analytics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3Analytics

What does 3Analytics do?

3Analytics sells a cloud-based, AI/ML/NLP-driven pharmacovigilance SaaS platform that helps pharmaceutical, medical device, vaccine, and cosmetics organizations detect safety signals, automate literature monitoring and ICSR extraction, manage regulatory intelligence across 100+ countries, and code medical device complaints using IMDRF standards. The platform is built on a proprietary ADR/AE Analytics Engine and is delivered primarily via enterprise subscriptions with associated professional services for implementation and customization.

Is 3Analytics a public or private company?

3Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was 3Analytics founded?

3Analytics was founded in 2020. It employs 51 to 100 people.

Where is 3Analytics based?

3Analytics is headquartered in Cupertino, United States, in the North America region.

How does 3Analytics make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services.

Who are 3Analytics's main competitors?

Direct peers on record are Oracle Health Sciences (Argus Safety), Veeva Systems (Vault Safety), ArisGlobal (LifeSphere), Insife, AB Cube and Instem (BioClin). IQVIA (Safety & Regulatory) is listed as a broad incumbent. Cognizant Life Sciences is listed as an others. Emerging players are Saama Technologies and AssurX.

Does 3Analytics have an API?

No public API is recorded for 3Analytics.

What industry is 3Analytics in?

3Analytics's product category is Pharmacovigilance Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGALAC, Signal Detection & Safety Analytics (Epidemiology/RWE). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales